Find a Clinical Trial
Filter
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
Relapsed refractory myeloma
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
M23-362
Diffuse large B-cell lymphoma, Follicular lymphoma, Lymphomas (adult)
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Takeda footprint
Neonatal care
All genders
Recruiting now
Department of Obstetrics + Gynecology
HGB-210
Sickle cell anemia
All genders
Recruiting now
Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center
A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)
All genders
Recruiting now
Department of Medicine, Cancer Center
Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
Diffuse large B-cell lymphoma
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
BoppliTM blood pressure monitoring
Neonatal care
All genders
Recruiting now
Department of Pediatrics
The Connection study
Premature babies, Premature birth
All genders
No minimum age
Recruiting now
Department of Obstetrics + Gynecology
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Lymphomas (adult)
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
ANHL1931
Lymphoma
All genders
Recruiting now
Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center